COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34

To provide antibodies, compounds, pharmaceutical compositions and methods for treating immune-mediated diseases such as Alzheimer's disease or tauopathy diseases.SOLUTION: Provided herein is an antibody that binds to human IL-34, where the antibody comprises a heavy chain variable region (VH) a...

Full description

Saved in:
Bibliographic Details
Main Authors ANDREW DIXON SKORA, YE MING, ADAM S FLEISHER, ALBERT LO, SARAH ELISABETH RAINES, ROBIN ELIZABETH WALSH, MARK MINTUN, ELIZABETH ANNE WEST, MARCIO CHEDID, MEGAN BRITTANY LANNAN, VICTOR H OBUNGU, JOHN RANDALL SIMS II
Format Patent
LanguageEnglish
Japanese
Published 16.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To provide antibodies, compounds, pharmaceutical compositions and methods for treating immune-mediated diseases such as Alzheimer's disease or tauopathy diseases.SOLUTION: Provided herein is an antibody that binds to human IL-34, where the antibody comprises a heavy chain variable region (VH) and a light chain variable region (VL), the VH comprises a heavy chain complementarity determining region (HCDR) HCDR1, HCDR2 and HCDR3, and the VL comprises a light chain complementarity determining region (LCDR) LCDR1, LCDR2 and LCDR3. Also provided is an agent for treating an immune-mediated disease selected from the group consisting of Alzheimer's disease, a tauopathy disease, Sjogren syndrome (SS), rheumatoid arthritis (RA), inflammatory bowel disease (IBD), atopic dermatitis, kidney diseases, sepsis, and/or non-alcoholic fatty liver disease (NAFLD).SELECTED DRAWING: None 【課題】アルツハイマー病又はタウオパチー疾患などの免疫介在性疾患を治療するための抗体、化合物、医薬組成物及び方法を提供する。【解決手段】ヒトIL-34に結合する抗体であって、前記抗体が、重鎖可変領域(VH)と、軽鎖可変領域(VL)と、を含み、前記VHが、重鎖相補性決定領域(HCDR)HCDR1、HCDR2、及びHCDR3を含み、前記VLが、軽鎖相補性決定領域(LCDR)LCDR1、LCDR2、及びLCDR3を含む、抗体を提供する。また、前記抗体を含む、アルツハイマー病、タウオパチー病、シェーグレン症候群(SS)、関節リウマチ(RA)、炎症性腸疾患(IBD)、アトピー性皮膚炎、腎疾患、敗血症、及び/又は非アルコール性脂肪性肝疾患(NAFLD)からなる群から選択される免疫介在性疾患の治療剤を提供する。【選択図】なし
AbstractList To provide antibodies, compounds, pharmaceutical compositions and methods for treating immune-mediated diseases such as Alzheimer's disease or tauopathy diseases.SOLUTION: Provided herein is an antibody that binds to human IL-34, where the antibody comprises a heavy chain variable region (VH) and a light chain variable region (VL), the VH comprises a heavy chain complementarity determining region (HCDR) HCDR1, HCDR2 and HCDR3, and the VL comprises a light chain complementarity determining region (LCDR) LCDR1, LCDR2 and LCDR3. Also provided is an agent for treating an immune-mediated disease selected from the group consisting of Alzheimer's disease, a tauopathy disease, Sjogren syndrome (SS), rheumatoid arthritis (RA), inflammatory bowel disease (IBD), atopic dermatitis, kidney diseases, sepsis, and/or non-alcoholic fatty liver disease (NAFLD).SELECTED DRAWING: None 【課題】アルツハイマー病又はタウオパチー疾患などの免疫介在性疾患を治療するための抗体、化合物、医薬組成物及び方法を提供する。【解決手段】ヒトIL-34に結合する抗体であって、前記抗体が、重鎖可変領域(VH)と、軽鎖可変領域(VL)と、を含み、前記VHが、重鎖相補性決定領域(HCDR)HCDR1、HCDR2、及びHCDR3を含み、前記VLが、軽鎖相補性決定領域(LCDR)LCDR1、LCDR2、及びLCDR3を含む、抗体を提供する。また、前記抗体を含む、アルツハイマー病、タウオパチー病、シェーグレン症候群(SS)、関節リウマチ(RA)、炎症性腸疾患(IBD)、アトピー性皮膚炎、腎疾患、敗血症、及び/又は非アルコール性脂肪性肝疾患(NAFLD)からなる群から選択される免疫介在性疾患の治療剤を提供する。【選択図】なし
Author MEGAN BRITTANY LANNAN
ELIZABETH ANNE WEST
MARCIO CHEDID
ANDREW DIXON SKORA
ADAM S FLEISHER
MARK MINTUN
ROBIN ELIZABETH WALSH
YE MING
SARAH ELISABETH RAINES
ALBERT LO
VICTOR H OBUNGU
JOHN RANDALL SIMS II
Author_xml – fullname: ANDREW DIXON SKORA
– fullname: YE MING
– fullname: ADAM S FLEISHER
– fullname: ALBERT LO
– fullname: SARAH ELISABETH RAINES
– fullname: ROBIN ELIZABETH WALSH
– fullname: MARK MINTUN
– fullname: ELIZABETH ANNE WEST
– fullname: MARCIO CHEDID
– fullname: MEGAN BRITTANY LANNAN
– fullname: VICTOR H OBUNGU
– fullname: JOHN RANDALL SIMS II
BookMark eNrjYmDJy89L5WTQc_b3DfAP9XMJVnD0c1HwdQ3x8AeyQxyD3F1DPP3cFTz9QlyDfFxDvT39dI1NeBhY0xJzilN5oTQ3g5Kba4izh25qQX58anFBYnJqXmpJvFeAkYGRsYGZuYWxkaMxUYoAJwgn6w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate インターロイキン-34を標的とする化合物及び方法
ExternalDocumentID JP2023067832A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2023067832A3
IEDL.DBID EVB
IngestDate Fri Oct 04 04:55:45 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2023067832A3
Notes Application Number: JP20220172479
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230516&DB=EPODOC&CC=JP&NR=2023067832A
ParticipantIDs epo_espacenet_JP2023067832A
PublicationCentury 2000
PublicationDate 20230516
PublicationDateYYYYMMDD 2023-05-16
PublicationDate_xml – month: 05
  year: 2023
  text: 20230516
  day: 16
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies ELI LILLY & CO
RelatedCompanies_xml – name: ELI LILLY & CO
Score 3.6031113
Snippet To provide antibodies, compounds, pharmaceutical compositions and methods for treating immune-mediated diseases such as Alzheimer's disease or tauopathy...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Title COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230516&DB=EPODOC&locale=&CC=JP&NR=2023067832A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhT1DedijqVItK3KG3TdXsosjXt5rAfzFb2NpYtARV0uIp_30vsdE97u-Tg8gH3lcvdAdxwbrVVtzoiHEEJanxKUAkKQj0puSuEN9ft3uKkNSjocOyOa_C2yoXRdUK_dXFE5KgZ8nup5fXi_xGL6b-Vyzv-glMf91HuM7PyjtGedq2WyXp-mKUsDcwg8IeZmYx-cSiYHbu7BdvKjlaF9sPnnkpLWazrlOgAdjIk914eQu112oC9YNV6rQG7cRXxRrBivuUR3AZpnKVFwp6MbsKMOMwHKcJ5d9QP84ekb-jyto9hgR45cegxXEdhHgwILjz5O-ZkmK1t0jmBOvr_4hQMz6XetN2RvG1NKeUzLm05l_ZMirndkRY9g-YGQucbsU3YVyMVDrdaF1AvP7_EJWrZkl_p2_kBqK18Bg
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8JADG8QjfimqEHxYzFmb9NsuzF4WMzYBmPuKzgMbwsHd4maKJEZ_327cyhPvDXXpPeRtL3f9doC3FKqdstudQrTGVHQ4xMFnSBTiMk5NRgzF6LdWxR3_AkJpsa0Bm_rXBhRJ_RbFEdEjZqjvhfCXi__H7Fc8bdydU9fcOjjYZBZrlyhY7xPG2pHdvuWlyZu4siOYwWpHI9_eWiYdc3egV0TMaHASs_9Mi1luelTBoewl6K49-IIaq-zJjScdeu1JuxHVcQbyUr5Vsdw5yRRmkxi90myY1eKvMxPkM7s8dDLRvFQEuVtQ2-CiFzRyQncDLzM8RWcOP_bZh6kG4vUT6GO-J-1QDINYs66PU676owQOqdc4wuuzTlbaD2ukjNobxF0vpV7DQ0_i8I8HMWPbTgoOWVoXO1cQL34_GKX6HELeiVO6geaB37w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+AND+METHODS+TARGETING+INTERLEUKIN-34&rft.inventor=ANDREW+DIXON+SKORA&rft.inventor=YE+MING&rft.inventor=ADAM+S+FLEISHER&rft.inventor=ALBERT+LO&rft.inventor=SARAH+ELISABETH+RAINES&rft.inventor=ROBIN+ELIZABETH+WALSH&rft.inventor=MARK+MINTUN&rft.inventor=ELIZABETH+ANNE+WEST&rft.inventor=MARCIO+CHEDID&rft.inventor=MEGAN+BRITTANY+LANNAN&rft.inventor=VICTOR+H+OBUNGU&rft.inventor=JOHN+RANDALL+SIMS+II&rft.date=2023-05-16&rft.externalDBID=A&rft.externalDocID=JP2023067832A